Literature DB >> 21360961

[The influence of tobacco smoking on concentration of the pregnancy-associated plasma protein A (PAPP-A) in pregnant women].

Joanna Gajewska1, Magdalena Chełchowska, Alicja Ceran, Jadwiga Ambroszkiewicz, Teresa Laskowska-Klita.   

Abstract

This article presents a review of scientific literature concerning adverse effect of tobacco smoking on concentration of the pregnancy-associated plasma protein A (PAPP-A) in pregnant women. PAPP-A is produced in great amounts during pregnancy by the syncytiotrofoblast, but can be also detected in a variety of cell types such as fibroblasts, osteoblasts and vascular smooth muscle cells (VSMC). We describe the structure of PAPP-A and its function as an insulin-like growth factor binding proteins (IGFBPs) protease with a focus on data obtained in tobacco smoking pregnant women. We also discuss the results of studies indicating a correlation between smoking and deficit of PAPP-A in the first trimester of pregnancy. The review summarizes possible mechanisms relating tobacco smoking to the changes of PAPP-A concentration during pregnancy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21360961

Source DB:  PubMed          Journal:  Przegl Lek        ISSN: 0033-2240


  2 in total

1.  Serum pregnancy-associated plasma protein A levels in the first, second and third trimester of pregnancy: relation to newborn anthropometric parameters and maternal tobacco smoking.

Authors:  Magdalena Chełchowska; Joanna Gajewska; Joanna Mazur; Jadwiga Ambroszkiewicz; Tomasz M Maciejewski; Jerzy Leibschang
Journal:  Arch Med Sci       Date:  2016-10-24       Impact factor: 3.318

2.  Pregnancy-Associated Plasma Protein A (PAPP-A) Concentration in Population of Healthy Young People: Interactions with Tobacco Smoke and Anti-oxidative Status.

Authors:  Magdalena Szumska; Aleksandra Damasiewicz-Bodzek; Justyna Czubilińska; Michał Długaszek; Kaja Gawlik; Anna Krywult; Konrad Synowiec; Tomasz Wielkoszyński; Krystyna Tyrpień-Golder
Journal:  Cardiovasc Toxicol       Date:  2019-04       Impact factor: 3.231

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.